Physician profile
Kenneth Dardick
NPI 1316930266
$145,745.23
in general payments reported to CMS, 2019-2025
45 companies · $20K in 2025
The $20K reported for 2025 was more than what 99% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $43K · 2020: $11K · 2021: $16K · 2022: $13K · 2023: $20K · 2024: $23K · 2025: $20K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $61K · Food and Beverage: $1,972.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $60,525.50 |
| Food and Beverage | $1,971.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Valneva Austria Gmbh | $83,494.36 | 2019-2023 | |
| Pfizer INC. | $57,889.84 | 2019-2025 | |
| Novo Nordisk INC | $524.07 | 2019-2025 | Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals Lp | $512.22 | 2019-2025 | Breztri, Bevespi Aerosphere, Airsupra |
| Lilly USA, LLC | $334.54 | 2019-2025 | Mounjaro, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $289.99 | 2020-2022 | |
| Abbvie INC. | $280.85 | 2021-2025 | Vraylar |
| Merck Sharp & Dohme LLC | $270.61 | 2019-2025 | Gardasil 9, Capvaxive, Gardasil |
| Glaxosmithkline, LLC. | $170.62 | 2019-2023 | Shingrix, Arexvy |
| Bayer Healthcare Pharmaceuticals INC. | $156.31 | 2022-2024 | |
| Exact Sciences Corporation | $132.15 | 2023-2025 | Cologuard Collection Kit |
| Eisai INC. | $129.42 | 2020-2022 | |
| Amgen INC. | $128.85 | 2020-2025 | Evenity, Prolia, Otezla |
| Otsuka America Pharmaceutical, INC. | $112.16 | 2022-2025 | Rexulti |
| Indivior INC. | $111.98 | 2024-2025 | Sublocade |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Dardick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.